Adeka Corporation (TYO:4401)

Japan flag Japan · Delayed Price · Currency is JPY
3,864.00
-64.00 (-1.63%)
May 1, 2026, 3:30 PM JST
Market Cap378.12B +70.9%
Revenue (ttm)407.55B -0.5%
Net Income25.67B -0.2%
EPS253.91 +0.6%
Shares Out97.86M
PE Ratio15.22
Forward PE13.56
Dividend104.00 (2.69%)
Ex-Dividend DateMar 30, 2026
Volume446,000
Average Volume348,810
Open3,871.00
Previous Close3,928.00
Day's Range3,839.00 - 3,904.00
52-Week Range2,508.00 - 5,104.00
Beta0.83
RSI45.59
Earnings DateMay 14, 2026

About Adeka

Adeka Corporation engages in chemicals, food products, and life science businesses. The company offers polymer additives, such as antioxidants, UV absorbers/hindered amine light stabilizers, nucleating agents/clarifiers, metal deactivators/additives for filled polymers, flame retardants, epoxy type stabilizers/lubricants/processability improvers/water dispersion type stabilizers; plasticizers/PVC stabilizers; and photo/thermal curing materials, initiators, polymerizable materials, resist materials, thermal paper materials, semiconductor materia... [Read more]

Sector Materials
Founded 1917
Employees 5,453
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4401
Full Company Profile

Financial Performance

In fiscal year 2025, Adeka's revenue was 407.15 billion, an increase of 1.84% compared to the previous year's 399.77 billion. Earnings were 25.02 billion, an increase of 8.89%.

Financial Statements

News

Adeka Earnings Call Transcript: Q3 2026

Net sales rose slightly year-over-year, but operating profit declined due to higher fixed costs. Guidance for full-year sales and profit was revised downward, with recovery expected in Q4, especially in polymer additives and semiconductor materials.

3 months ago - Transcripts

Adeka Earnings Call Transcript: Q2 2026

First-half FY2025 saw modest sales and profit growth, led by strong life science results offsetting weakness in chemicals and food. Full-year guidance is reaffirmed, with ongoing share buybacks and a stable dividend policy.

5 months ago - Transcripts

Adeka Earnings Call Transcript: Q1 2026

Q1 FY2025 saw higher sales and profits year-over-year, led by strong Life Science segment growth and resilient pricing, despite challenges in chemicals and food products. Full-year guidance remains unchanged, with a share buyback announced.

9 months ago - Transcripts

Adeka Earnings Call Transcript: Q1 2025

Q1 saw YoY growth in sales and profit, with strong performance in Polymer Additives, Functional Chemicals, and Food Products, but a loss in Life Science. Full-year guidance was raised for the first half, with continued focus on semiconductors and environmental materials.

1 year ago - Transcripts

Adeka Earnings Call Transcript: Q2 2024

2 years ago - Transcripts